GG
Well-Known Member
Found this concerning though:
The interim results of the study, announced in late 2013, met the FDA goals, according to the company.
The FDA approval includes requirements for post-marketing research, including a heart outcomes trial to look at any heart and stroke risks. The company must also look at the potential for interactions between Contrave and other drugs, evaluate the best dose for patients with liver or kidney problems, look at the safety of the drug in children, and do other research.
http://www.webmd.com/diet/20140911/contrave-weight-loss-drug?page=3
I don't have any liver or kidney problems, but do have high blood pressure.
GG
The interim results of the study, announced in late 2013, met the FDA goals, according to the company.
The FDA approval includes requirements for post-marketing research, including a heart outcomes trial to look at any heart and stroke risks. The company must also look at the potential for interactions between Contrave and other drugs, evaluate the best dose for patients with liver or kidney problems, look at the safety of the drug in children, and do other research.
http://www.webmd.com/diet/20140911/contrave-weight-loss-drug?page=3
I don't have any liver or kidney problems, but do have high blood pressure.
GG